Philadelphia Pharmaceuticals Company (ASE:PHIL)
Jordan · Delayed Price · Currency is JOD 1.600
0.00 (0.00%)
At close: Dec 31, 2025
ASE:PHIL Income Statement
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 9.11 | 8.76 | 8.4 | 8.42 | 6.6 | 7.66 | Upgrade | |
Revenue Growth (YoY) | 1.83% | 4.25% | -0.12% | 27.48% | -13.77% | -16.01% | Upgrade |
Cost of Revenue | 4.78 | 4.64 | 4.4 | 4.51 | 3.47 | 4.2 | Upgrade |
Gross Profit | 4.33 | 4.12 | 4 | 3.91 | 3.13 | 3.46 | Upgrade |
Selling, General & Admin | 2.46 | 2.3 | 2.21 | 2.59 | 2.41 | 2.85 | Upgrade |
Research & Development | 0.44 | 0.42 | 0.44 | 0.22 | - | 0.18 | Upgrade |
Operating Expenses | 2.9 | 2.72 | 2.65 | 2.81 | 2.41 | 3.03 | Upgrade |
Operating Income | 1.43 | 1.4 | 1.35 | 1.1 | 0.72 | 0.43 | Upgrade |
Interest Expense | -0.3 | -0.35 | -0.34 | -0.24 | -0.23 | -0.3 | Upgrade |
Other Non Operating Income (Expenses) | 0.02 | -0 | 0 | 0 | 0.01 | 0.04 | Upgrade |
EBT Excluding Unusual Items | 1.16 | 1.04 | 1.02 | 0.87 | 0.49 | 0.17 | Upgrade |
Pretax Income | 1.16 | 1.04 | 1.02 | 0.87 | 0.49 | 0.17 | Upgrade |
Income Tax Expense | 0.24 | 0.22 | 0.21 | 0.16 | 0.08 | 0.03 | Upgrade |
Net Income | 0.91 | 0.82 | 0.81 | 0.7 | 0.41 | 0.14 | Upgrade |
Net Income to Common | 0.91 | 0.82 | 0.81 | 0.7 | 0.41 | 0.14 | Upgrade |
Net Income Growth | 9.14% | 1.77% | 15.13% | 70.91% | 189.48% | -88.87% | Upgrade |
Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | 8 | Upgrade |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | 8 | Upgrade |
EPS (Basic) | 0.12 | 0.11 | 0.11 | 0.09 | 0.05 | 0.02 | Upgrade |
EPS (Diluted) | 0.12 | 0.11 | 0.11 | 0.09 | 0.05 | 0.02 | Upgrade |
EPS Growth | 9.14% | 1.77% | 15.13% | 70.91% | 189.49% | -88.87% | Upgrade |
Free Cash Flow | 2.01 | 1.53 | 1.03 | 1.94 | 2.94 | 1.56 | Upgrade |
Free Cash Flow Per Share | 0.27 | 0.20 | 0.14 | 0.26 | 0.39 | 0.21 | Upgrade |
Dividend Per Share | 0.070 | 0.070 | 0.070 | 0.060 | 0.060 | - | Upgrade |
Dividend Growth | - | - | 16.67% | - | - | - | Upgrade |
Gross Margin | 47.55% | 47.03% | 47.64% | 46.42% | 47.47% | 45.16% | Upgrade |
Operating Margin | 15.74% | 15.94% | 16.12% | 13.05% | 10.90% | 5.58% | Upgrade |
Profit Margin | 10.02% | 9.38% | 9.60% | 8.33% | 6.21% | 1.85% | Upgrade |
Free Cash Flow Margin | 22.10% | 17.43% | 12.30% | 23.07% | 44.57% | 20.42% | Upgrade |
EBITDA | 1.46 | 1.67 | 1.65 | 1.22 | 0.88 | 0.71 | Upgrade |
EBITDA Margin | 15.97% | 19.08% | 19.62% | 14.48% | 13.32% | 9.23% | Upgrade |
D&A For EBITDA | 0.02 | 0.28 | 0.29 | 0.12 | 0.16 | 0.28 | Upgrade |
EBIT | 1.43 | 1.4 | 1.35 | 1.1 | 0.72 | 0.43 | Upgrade |
EBIT Margin | 15.74% | 15.94% | 16.12% | 13.05% | 10.90% | 5.58% | Upgrade |
Effective Tax Rate | 21.02% | 21.03% | 21.02% | 19.00% | 16.94% | 15.00% | Upgrade |
Advertising Expenses | - | - | - | 0.21 | 0.2 | 0.16 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.